2.82 USD
+0.12 (+4.44%)
ChartMill assigns a Buy % Consensus number of 86% to CNTB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.06. This target is 185.74% above the current price.
CNTB was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CNTB.
In the previous month the buy percentage consensus was at a similar level.
CNTB was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-01 | Lake Street | Initiate | Buy |
| 2025-11-13 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-31 | BTIG | Initiate | Buy |
| 2025-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Initiate | Buy |
| 2023-09-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-02-08 | SVB Leerink | Maintains | Outperform |
| 2022-06-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-05-05 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-05-04 | SVB Leerink | Maintains | Outperform |
| 2022-01-06 | SVB Leerink | Maintains | Outperform |
| 2021-07-02 | CICC | Initiate | Outperform |
| 2021-04-13 | SVB Leerink | Initiate | Outperform |
| 2021-04-13 | Jefferies | Initiate | Buy |
CONNECT BIOPHARMA HOLDINGS L / CNTB FAQ
What do analysts expect the price target to be for CONNECT BIOPHARMA HOLDINGS L (CNTB)?
10 analysts have analysed CNTB and the average price target is 8.06 USD. This implies a price increase of 185.74% is expected in the next year compared to the current price of 2.82.
Can you provide the consensus rating for CONNECT BIOPHARMA HOLDINGS L stock?
The consensus rating for CONNECT BIOPHARMA HOLDINGS L (CNTB) is 86 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for CNTB stock?
The number of analysts covering CONNECT BIOPHARMA HOLDINGS L (CNTB) is 10.